Successor of Prof. Jochen Büchs starting April 2023 - Welcome Dr. Jørgen Magnus!
As of 3 April 2023, Dr. Jørgen Magnus will begin his work as head of the Chair of Bioprocess Engineering. Prof. Jochen Büchs will support him in a six-month overlap phase until the end of September 2023.
Jørgen Magnus holds a Master of Chemical Engineering from the University of Manchester, Institute of Science and Technology and a PhD in Biochemical Engineering from the University of Stuttgart. He worked for NNE Pharmaplan on design, construction, and commissioning of pharmaceutical production facilities before he joined the Bayer AG in 2009. There, he worked on topics related to Industrial and Pharmaceutical Biotechnology and initiated process development programs for the fermentative production of aniline and phenol from sugar. In addition to a project lead for the development of a continuous process for monoclonal antibodies, he was head of the Bioprocess Technology group for five years, before taking on the position in Strategic Program Management Lead Cell and Gene Therapy.
His interests include microbial and cell fermentation, continuous processing, facility design and production technologies for biobased chemicals, as well as biopharmaceutical applications such as antibodies, mRNA and cell and gene therapy.
Jørgen Magnus has three children and lives in Düsseldorf with his family.
We warmly welcome him to AVT and wish him a great start!